Pharmafile Logo
Pharmafocus logo
Advanced Search

HCV

Showing 12 posts of 27 posts found.

Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

News
Merck image

Merck buys Idenix

June 10, 2014
Manufacturing and Production, Sales and Marketing HCV, IDX21437, IDX21459, Merck, hep C, idenix

Merck is to improve its pipeline of hepatitis C virus (HCV) treatments by splashing out $3.85 billion on biopharma firm …

News
sovaldi iamge

Sovaldi performs for Gilead

April 24, 2014
Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …

News

Europe nod for Gilead HCV pill

January 20, 2014
Sales and Marketing FDA, Gilead, HCV, hep C, sofosbuvir, sovaldi

Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has been given the green light by the European Commission, just a …

News
BMS image

BMS files oral hep C treatment

November 5, 2013
Sales and Marketing BMS, HCV, dvc, hep C

Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …

News
janssen image

Janssen takes on GSK hep C drug

October 9, 2013
Research and Development, Sales and Marketing GSK, GSK2336805, HCV, Janssen

Janssen Pharmaceuticals has acquired one of GlaxoSmithKline’s investigational hepatitis C treatments and will look at it in combination with various …

News

High cure rate for Boehringer HCV drug

June 11, 2013
Research and Development, Sales and Marketing Boehringer Ingelheim, HCV

One of Boehringer Ingelheim’s pipeline drugs has achieved high response rates in patients with chronic genotype-1 hepatitis C virus (HCV) in …

News
Merck image

HCV agreement for Merck and BMS

April 23, 2013
Research and Development, Sales and Marketing BMS, HCV, Merck

Merck & Co and Bristol-Myers Squibb have signed a non-exclusive agreement to conduct a Phase II trial looking at a …

News

Patient death halts BMS hep C trial

August 30, 2012
Sales and Marketing BMS, HCV, hepatitis C

Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …

News

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011
Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …

News

Boehringer hails hepatitis C candidate

November 9, 2011
Sales and Marketing BI201335, Boehringer Ingelheim, HCV, Incivo, Victrelis, hepatitis C

Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …

News

New hepatitis C drug offers cure for more patients

December 17, 2010
Research and Development, Sales and Marketing HCV, Janssen, hepatitis C, liver disease, telaprevir

A new treatment from Janssen which could help cure many more patients with hepatitis C has been submitted in Europe. …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026